Screener
DocuSign DOCU R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by DocuSign in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: DocuSign’s 10-Q, filed June 5, 2026.
- Filed
- Jun 5, 2026, 4:50 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001261333-26-000074
| (in thousands, except per share data) | Three Months Ended April 30, 2026 | Three Months Ended April 30, 2025 |
|---|---|---|
| Gross profit | 658,965 | 606,385 |
| Operating expenses: | ||
| Sales and marketing | 296,175 | 296,413 |
| Research and development | 159,586 | 159,447 |
| General and administrative | 91,895 | 90,270 |
| Total operating expenses | 547,656 | 546,130 |
| Income from operations | 111,309 | 60,255 |
| Interest expense | (551) | (478) |
Item 1. Financial Statements (unaudited)
FAQ
- What is DocuSign's R&D?
- DocuSign (DOCU) reported R&D of $159.59M in Q1 2026.
- How has DocuSign's R&D changed year-over-year?
- DocuSign's R&D increased by 0.1% year-over-year, from $159.45M to $159.59M.
- What is the long-term trend for DocuSign's R&D?
- Over 4 years (2022 to 2026), DocuSign's R&D has grown at a 14.0% compound annual growth rate (CAGR), from $393.36M to $664.99M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about DocuSign's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude